Generic Portal

— Research Explorer

Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1136/bmjopen-2022-064944
Final published version

Charlotte M. Verburgt
Katherine A. Dunn
Anthony Otley
Melvin B. Heyman
Sofia Verstraete
Withney Sunseri
Francisco Sylvester
Tim de Meij
Andre Comeau
Morgan Langille
Wouter J. de Jonge
Marc A. Benninga
Johan E. van Limbergen

Original language	English
Article number	e064944
Pages (from-to)	e064944
Journal	BMJ open
Volume	13
Issue number	2
DOIs	https://doi.org/10.1136/bmjopen-2022-064944
Publication status	Published - 1 Feb 2023

Research areas

clinical trials, inflammatory bowel disease, microbiology, paediatric gastroenterology

ID: 32506167